发明名称 METHOD OF PREDICTING CHEMORADIOTHERAPY EFFICIENCY IN PATIENTS WITH DISSEMINATED SKIN MELANOMA
摘要 FIELD: medicine. ^ SUBSTANCE: in order to realise the method before starting complex treatment content of general triiodthyronine in patients' blood is determined, and if its concentration is within 1.35-1.70 nmole/l reduction of tumour size on 25-50% and more after performing chemoradiotherapy is predicted, if concentration of triiodthyronine is within 0.52-1.10 nmole/l progression of disease after performing chemoradiotherapy is predicted. ^ EFFECT: obtained results of triiodthyronine content in case of chemoradiotherapy are a prognostic factor of treatment efficiency and can be used in treatment of patients with disseminated skin melanoma for timely selection of patients and application of proper treatment tactics. ^ 1 tbl, 2 ex
申请公布号 RU2398238(C1) 申请公布日期 2010.08.27
申请号 RU20080152470 申请日期 2008.12.29
申请人 FEDERAL'NOE GOSUDARSTVENNOE UCHREZHDENIE "ROSTOVSKIJ NAUCHNO-ISSLEDOVATEL'SKIJ ONKOLOGICHESKIJ INSTITUT ROSMEDTEKHNOLOGIJ";SIDORENKO JURIJ SERGEEVICH;DZHABAROV FARKHAD RASIMOVICH;KOZLOVA MARGARITA BORISOVNA;FRANTSIJANTS ELENA MIKHAJLOVNA;KOSHELEVA NATAL'JA GENNAD'EVNA 发明人 SIDORENKO JURIJ SERGEEVICH;DZHABAROV FARKHAD RASIMOVICH;KOZLOVA MARGARITA BORISOVNA;FRANTSIJANTS ELENA MIKHAJLOVNA;KOSHELEVA NATAL'JA GENNAD'EVNA
分类号 G01N33/78 主分类号 G01N33/78
代理机构 代理人
主权项
地址